OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
January 02, 2023
In light of increasingly stringent sustainability requirements, bio/pharma companies need to make sure they formulate effective ESG strategies.
The latest report from Clarivate has been published, highlighting 15 potential blockbusters to watch out for in 2023, the majority of which are personalized medicines.
December 02, 2022
Pharmaceutical Technology Europe got the scoop on Agilent's new Dissolution Testing Centre of Excellence in Craven Arms, UK.
Dissolution testing is experiencing a refresh thanks to a variety of market drivers.
Anti-obesity drugs have the potential to be the next blockbusters, according to market analysis.
November 03, 2022
Opportunities and developments in particle engineering are providing developers with the tools to advance drug candidates successfully.